| Kelly Ann Cissell, | |
|
227 E Main St, Festus, MO 63028-1952 | |
| (636) 931-2700 | |
| (636) 296-1961 |
| Full Name | Kelly Ann Cissell |
|---|---|
| Gender | Female |
| Speciality | Marriage & Family Therapist |
| Location | 227 E Main St, Festus, Missouri |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225300759 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | 2007035677 (Missouri) | Primary |
| Entity Name | Compass Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285619494 PECOS PAC ID: 1951206754 Enrollment ID: O20040408000955 |
News Archive
Disorders related to the abuse of alcohol contribute significantly to the burden of disease in the U.S., finds a new study in Alcoholism: Clinical and Experimental Research. Researchers estimated that in 2005, about 53,000 men and 12,000 women died from issues related to alcohol use disorders.
Tobacco use is the leading cause of preventable death and disability in the U.S., while heavy drinking ranks as the third leading cause of preventable death. Cigarette taxation has been recognized as one of the most significant policy instruments to reduce smoking.
A response to the Stakeholder Advisory Group's report on the effects of extremely low frequency electric and magnetic fields, by a member of SAGE.
An international team of researchers has found a group of mutations involved in T-cell acute lymphoblastic leukemia (T-ALL), and showed that a group of certain drugs, already in clinical use to treat other diseases, can eliminate the cells carrying these mutations.
MEI Pharma, Inc., an oncology company focused on the clinical development of novel therapies for cancer, announced today that the first patient has been dosed in a Phase Ib clinical study of its investigational mitochondrial inhibitor drug candidate ME-344 in combination with Hycamtin (topotecan) in patients with solid tumors, including small cell lung and ovarian cancers.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kelly Ann Cissell, 21 Municipal Dr, Arnold, MO 63010-1012 Ph: (636) 296-6206 | Kelly Ann Cissell, 227 E Main St, Festus, MO 63028-1952 Ph: (636) 931-2700 |
News Archive
Disorders related to the abuse of alcohol contribute significantly to the burden of disease in the U.S., finds a new study in Alcoholism: Clinical and Experimental Research. Researchers estimated that in 2005, about 53,000 men and 12,000 women died from issues related to alcohol use disorders.
Tobacco use is the leading cause of preventable death and disability in the U.S., while heavy drinking ranks as the third leading cause of preventable death. Cigarette taxation has been recognized as one of the most significant policy instruments to reduce smoking.
A response to the Stakeholder Advisory Group's report on the effects of extremely low frequency electric and magnetic fields, by a member of SAGE.
An international team of researchers has found a group of mutations involved in T-cell acute lymphoblastic leukemia (T-ALL), and showed that a group of certain drugs, already in clinical use to treat other diseases, can eliminate the cells carrying these mutations.
MEI Pharma, Inc., an oncology company focused on the clinical development of novel therapies for cancer, announced today that the first patient has been dosed in a Phase Ib clinical study of its investigational mitochondrial inhibitor drug candidate ME-344 in combination with Hycamtin (topotecan) in patients with solid tumors, including small cell lung and ovarian cancers.
› Verified 9 days ago
Mrs. Meredith Leigh Spezia, Couples Therapy Medicare: Medicare Enrolled Practice Location: 227 Main St, Festus, MO 63028 Phone: 636-931-2700 |